These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26765768)

  • 1. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
    Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
    Gredal O; Rosenbaum S; Topp S; Karlsborg M; Strange P; Werdelin L
    Neurology; 1997 Apr; 48(4):878-81. PubMed ID: 9109871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
    Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
    PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
    Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.
    Sako W; Izumi Y; Abe T; Haji S; Murakami N; Osaki Y; Matsumoto Y; Harada M; Kaji R
    Neurol Sci; 2021 Oct; 42(10):4257-4263. PubMed ID: 33594539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements.
    Block W; Karitzky J; Träber F; Pohl C; Keller E; Mundegar RR; Lamerichs R; Rink H; Ries F; Schild HH; Jerusalem F
    Arch Neurol; 1998 Jul; 55(7):931-6. PubMed ID: 9678310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
    Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T
    Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
    Pioro EP; Majors AW; Mitsumoto H; Nelson DR; Ng TC
    Neurology; 1999 Jul; 53(1):71-9. PubMed ID: 10408539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
    Blicher JU; Eskildsen SF; Stærmose TG; Møller AT; Figlewski K; Near J
    Sci Rep; 2019 Nov; 9(1):17593. PubMed ID: 31772352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
    Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G
    Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
    Han J; Ma L
    J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
    Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M
    Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
    Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
    Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.
    Kalra S; Cashman NR; Genge A; Arnold DL
    Neuroreport; 1998 Jun; 9(8):1757-61. PubMed ID: 9665596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
    Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U
    Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
    Kantorová E; Poláček H; Bittšanský M; Baranovičová E; Hnilicová P; Čierny D; Sivák Š; Nosáľ V; Zeleňák K; Kurča E
    Neurol Res; 2017 Apr; 39(4):323-330. PubMed ID: 28191860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
    Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.